MedTrace Logo

THRIVE Study: Positive Affect Training for Endocrine Therapy Medication Adherence

NCT06388304 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2026-01-21

No results posted yet for this study

Summary

The purpose of this study is to pilot and refine an online behavioral intervention based on Positive Affect Training (PAT) that aims to increase positive emotional attitudes and decrease negative emotional attitudes toward endocrine therapy (ET, i.e., anti-hormonal medication) and to increase positive affect and decrease negative affect more generally, among post-treatment breast cancer survivors who are prescribed ET to prevent recurrence of breast cancer.

Conditions

Interventions

BEHAVIORAL

THRIVE Online PAT Program

Online program: behavioral intervention based on Positive Affect Training (PAT)

Sponsors & Collaborators

  • Joanna Arch

    lead OTHER

Principal Investigators

  • Joanna Arch, PhD · University of Colorado, Boulder

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-12
Primary Completion
2025-04-18
Completion
2025-04-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06388304 on ClinicalTrials.gov